Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,220
archived clinical trials in
HIV / AIDS

Vitamin D HIV Study on Postmenopausal Women
The Effect of Vitamin D Repletion on Postmenopausal Women With HIV
Status: Enrolling
Updated:  12/31/1969
Columbia University Medical Center
477
mi
from 43215
New York, NY
Vitamin D HIV Study on Postmenopausal Women
The Effect of Vitamin D Repletion on Postmenopausal Women With HIV
Status: Enrolling
Updated: 12/31/1969
Columbia University Medical Center
477
mi
from 43215
New York, NY
Click here to add this to my saved trials
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
2108
mi
from 43215
San Francisco, CA
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2108
mi
from 43215
San Francisco, CA
Click here to add this to my saved trials
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
328
mi
from 43215
Washington,
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
328
mi
from 43215
Washington,
Click here to add this to my saved trials
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
994
mi
from 43215
Coral Gables, FL
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
994
mi
from 43215
Coral Gables, FL
Click here to add this to my saved trials
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
797
mi
from 43215
Orlando, FL
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
797
mi
from 43215
Orlando, FL
Click here to add this to my saved trials
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
424
mi
from 43215
Atlanta, GA
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
424
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
481
mi
from 43215
New York, NY
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
481
mi
from 43215
New York, NY
Click here to add this to my saved trials
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
351
mi
from 43215
Durham, NC
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
351
mi
from 43215
Durham, NC
Click here to add this to my saved trials
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
96
mi
from 43215
Cincinnati, OH
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
96
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
414
mi
from 43215
Philadelphia, PA
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
414
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1064
mi
from 43215
Austin, TX
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1064
mi
from 43215
Austin, TX
Click here to add this to my saved trials
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
830
mi
from 43215
Longview, TX
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
830
mi
from 43215
Longview, TX
Click here to add this to my saved trials
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
5386
mi
from 43215
Ciudad de Buenos Aires,
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
5386
mi
from 43215
Ciudad de Buenos Aires,
Click here to add this to my saved trials
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
905
mi
from 43215
Dallas, TX
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
905
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Immune Responses to Two Experimental HIV Vaccines in Healthy Adults
VRC 016: A Phase 1b Open-Label, Randomized Clinical Trial to Evaluate Early Innate and Adaptive Immune Responses to the Investigational HIV-1 Vaccines: VRC-HIVADV014-00-VP and VRC-HIVDNA016-00-VP in Ad5 Seronegative Healthy Adults
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
Immune Responses to Two Experimental HIV Vaccines in Healthy Adults
VRC 016: A Phase 1b Open-Label, Randomized Clinical Trial to Evaluate Early Innate and Adaptive Immune Responses to the Investigational HIV-1 Vaccines: VRC-HIVADV014-00-VP and VRC-HIVDNA016-00-VP in Ad5 Seronegative Healthy Adults
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
Click here to add this to my saved trials
Integrated Treatment for Smoking Cessation & Anxiety in People With HIV
Integrated Treatment for Smoking Cessation & Anxiety in People With HIV
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
643
mi
from 43215
Boston, MA
Integrated Treatment for Smoking Cessation & Anxiety in People With HIV
Integrated Treatment for Smoking Cessation & Anxiety in People With HIV
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated:  12/31/1969
Alabama Therapeutics CRS (5801)
492
mi
from 43215
Birmingham, AL
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated: 12/31/1969
Alabama Therapeutics CRS (5801)
492
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated:  12/31/1969
UCLA CARE Center CRS (601)
1972
mi
from 43215
Los Angeles, CA
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated: 12/31/1969
UCLA CARE Center CRS (601)
1972
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated:  12/31/1969
Usc Crs (1201)
1972
mi
from 43215
Los Angeles, CA
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated: 12/31/1969
Usc Crs (1201)
1972
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated:  12/31/1969
Stanford CRS (501)
2100
mi
from 43215
Palo Alto, CA
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated: 12/31/1969
Stanford CRS (501)
2100
mi
from 43215
Palo Alto, CA
Click here to add this to my saved trials
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated:  12/31/1969
Ucsd, Avrc Crs (701)
1951
mi
from 43215
San Diego, CA
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated: 12/31/1969
Ucsd, Avrc Crs (701)
1951
mi
from 43215
San Diego, CA
Click here to add this to my saved trials
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated:  12/31/1969
Ucsf Aids Crs (801)
2107
mi
from 43215
San Francisco, CA
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated: 12/31/1969
Ucsf Aids Crs (801)
2107
mi
from 43215
San Francisco, CA
Click here to add this to my saved trials
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated:  12/31/1969
Harbor-UCLA Med. Ctr. CRS (603)
1983
mi
from 43215
Torrance, CA
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated: 12/31/1969
Harbor-UCLA Med. Ctr. CRS (603)
1983
mi
from 43215
Torrance, CA
Click here to add this to my saved trials
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated:  12/31/1969
University of Colorado Hospital CRS (6101)
1153
mi
from 43215
Aurora, CO
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated: 12/31/1969
University of Colorado Hospital CRS (6101)
1153
mi
from 43215
Aurora, CO
Click here to add this to my saved trials
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated:  12/31/1969
Georgetown University CRS (GU CRS) (1008)
328
mi
from 43215
Washington,
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated: 12/31/1969
Georgetown University CRS (GU CRS) (1008)
328
mi
from 43215
Washington,
Click here to add this to my saved trials
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated:  12/31/1969
The Ponce de Leon Ctr. CRS (5802)
436
mi
from 43215
Atlanta, GA
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated: 12/31/1969
The Ponce de Leon Ctr. CRS (5802)
436
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated:  12/31/1969
Northwestern University CRS (2701)
274
mi
from 43215
Chicago, IL
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated: 12/31/1969
Northwestern University CRS (2701)
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated:  12/31/1969
Rush University Medical Center (2702)
274
mi
from 43215
Chicago, IL
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated: 12/31/1969
Rush University Medical Center (2702)
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated:  12/31/1969
IHV Baltimore Treatment CRS (4651)
344
mi
from 43215
Baltimore, MD
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated: 12/31/1969
IHV Baltimore Treatment CRS (4651)
344
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated:  12/31/1969
Brigham and Women's Hosp. ACTG CRS (107)
643
mi
from 43215
Boston, MA
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp. ACTG CRS (107)
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital ACTG CRS (101)
643
mi
from 43215
Boston, MA
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital ACTG CRS (101)
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated:  12/31/1969
Beth Israel Deaconess Med. Ctr., ACTG CRS (103)
643
mi
from 43215
Boston, MA
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated: 12/31/1969
Beth Israel Deaconess Med. Ctr., ACTG CRS (103)
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated:  12/31/1969
New Jersey Medical School-Adult Clinical Research Ctr. CRS (31477)
468
mi
from 43215
Newark, NJ
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated: 12/31/1969
New Jersey Medical School-Adult Clinical Research Ctr. CRS (31477)
468
mi
from 43215
Newark, NJ
Click here to add this to my saved trials
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated:  12/31/1969
Bronx-Lebanon Hosp. Ctr. CRS (31469)
486
mi
from 43215
Bronx, NY
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated: 12/31/1969
Bronx-Lebanon Hosp. Ctr. CRS (31469)
486
mi
from 43215
Bronx, NY
Click here to add this to my saved trials
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated:  12/31/1969
HIV Prevention & Treatment CRS (30329)
477
mi
from 43215
New York, NY
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated: 12/31/1969
HIV Prevention & Treatment CRS (30329)
477
mi
from 43215
New York, NY
Click here to add this to my saved trials
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated:  12/31/1969
Cornell CRS (7804)
477
mi
from 43215
New York, NY
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated: 12/31/1969
Cornell CRS (7804)
477
mi
from 43215
New York, NY
Click here to add this to my saved trials
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated:  12/31/1969
NY Univ. HIV/AIDS CRS (401)
477
mi
from 43215
New York, NY
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated: 12/31/1969
NY Univ. HIV/AIDS CRS (401)
477
mi
from 43215
New York, NY
Click here to add this to my saved trials
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated:  12/31/1969
AIDS Care CRS (1108)
355
mi
from 43215
Rochester, NY
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated: 12/31/1969
AIDS Care CRS (1108)
355
mi
from 43215
Rochester, NY
Click here to add this to my saved trials
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated:  12/31/1969
University of Rochester ACTG CRS (1101)
355
mi
from 43215
Rochester, NY
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated: 12/31/1969
University of Rochester ACTG CRS (1101)
355
mi
from 43215
Rochester, NY
Click here to add this to my saved trials
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated:  12/31/1969
Unc Aids Crs
353
mi
from 43215
Chapel Hill, NC
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated: 12/31/1969
Unc Aids Crs
353
mi
from 43215
Chapel Hill, NC
Click here to add this to my saved trials
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated:  12/31/1969
Duke Univ. Med. Ctr. Adult CRS (1601)
354
mi
from 43215
Durham, NC
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated: 12/31/1969
Duke Univ. Med. Ctr. Adult CRS (1601)
354
mi
from 43215
Durham, NC
Click here to add this to my saved trials
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated:  12/31/1969
Regional Center for Infectious Disease, Wendover Medical Center CRS (3203)
321
mi
from 43215
Greensboro, NC
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated: 12/31/1969
Regional Center for Infectious Disease, Wendover Medical Center CRS (3203)
321
mi
from 43215
Greensboro, NC
Click here to add this to my saved trials
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated:  12/31/1969
Univ. of Cincinnati CRS (2401)
98
mi
from 43215
Cincinnati, OH
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated: 12/31/1969
Univ. of Cincinnati CRS (2401)
98
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated:  12/31/1969
Case CRS (2501)
127
mi
from 43215
Cleveland, OH
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated: 12/31/1969
Case CRS (2501)
127
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated:  12/31/1969
MetroHealth CRS (2503)
127
mi
from 43215
Cleveland, OH
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated: 12/31/1969
MetroHealth CRS (2503)
127
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated:  12/31/1969
The Ohio State Univ. AIDS CRS (2301)
1
mi
from 43215
Columbus, OH
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated: 12/31/1969
The Ohio State Univ. AIDS CRS (2301)
1
mi
from 43215
Columbus, OH
Click here to add this to my saved trials
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated:  12/31/1969
Hosp. of the Univ. of Pennsylvania CRS (6201)
416
mi
from 43215
Philadelphia, PA
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated: 12/31/1969
Hosp. of the Univ. of Pennsylvania CRS (6201)
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated:  12/31/1969
Pittsburgh CRS (1001)
162
mi
from 43215
Pittsburgh, PA
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated: 12/31/1969
Pittsburgh CRS (1001)
162
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated:  12/31/1969
The Miriam Hospital ACTG CRS (2951)
619
mi
from 43215
Providence, RI
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated: 12/31/1969
The Miriam Hospital ACTG CRS (2951)
619
mi
from 43215
Providence, RI
Click here to add this to my saved trials
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated:  12/31/1969
Vanderbilt Therapeutics CRS (3652)
332
mi
from 43215
Nashville, TN
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated: 12/31/1969
Vanderbilt Therapeutics CRS (3652)
332
mi
from 43215
Nashville, TN
Click here to add this to my saved trials